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HPLC proﬁlingIn South Africa, Salvia repens is used traditionally to treat sores, stomach ache and diarrhoea. The high perfor-
mance liquid chromatography (HPLC)-based activity proﬁling of S. repenswhole plant extract showed an active
abietane diterpene, identiﬁed as 12-methoxycarnosic acid (1) which showed antiprotozoal activity against
axenically grown Leishmania donovani amastigotes with an IC50 of 0.75 μM with marginal cytotoxicity against
the L6-cells (IC50, 17.3 μM).
© 2013 SAAB. Published by Elsevier B.V. All rights reserved.1. Introduction
Visceral leishmaniasis (VL), also known as “Kalaazar” is caused by
the intracellular protozoan Leishmania donovani and is transmitted by
the bite of infected phlebotomine sandﬂies. It has been estimated that
the annual global burden of VL is 500000 new cases with more than
59000 associated deaths (Den Boer et al., 2011). The control of VL relies
entirely on chemotherapy due to the lack of antileishmanial vaccines. In
poor countries, however, the use of leishmanicidal drugs is hampered
by high costs, toxicity and the emergence of resistance (Sundar et al.,
2007). In addition, the emergence of the human immunodeﬁciency
virus/acquired immunodeﬁciency disease (HIV/AIDS) has severely
compromised the control of VL (Alvar et al., 2008). Therefore, there is
an urgent need for the development of new leishmanial therapeutics.man immunodeﬁciency virus;
PLC, high performance liquid
hate buffer solution; FBS, foetal
agnetic resonance; MS, mass
erone; AR, androgen receptor;
27 31 260 3091.
lly).
y Elsevier B.V. All rights reserved.The genus Salvia (sage) is the largest in the Lamiaceae family with
over 900 species worldwide (Tan et al., 2002). Approximately 30 Salvia
species occur in southern Africa of which 26 are found in South Africa
especially in the Cape region (Codd, 1985). Salvia species are used in
folk medicine for the treatment of asthma, eczema, psoriasis and tuber-
culosis (Salimpour et al., 2011). In South Africa, Salvia species are used
against fever, headache and digestive disorders (Amabeoku et al.,
2001), and to treat sores (Auge et al., 2003). A decoction of the roots is
also used in South Africa for the treatment of stomach ache and diar-
rhoea (Auge et al., 2003). Several kinds of tanshinone-type diterpenoids
(Ślusarczyk et al., 2011) abietane and icetexane diterpenoids and
triterpenoic acids (Nieto et al., 2000; Tan et al., 2002; Kabouche et al.,
2007), phenolic acids, phenolic glycosides, ﬂavonoids and anthocyanins
(Walker and Sytsma, 2007) have been reported from Salvia species.
These constituents have shown various biological properties including
antiviral (Tada et al., 1994), antiprotozoal (Sairaﬁanpour et al., 2001;
Ślusarczyk et al., 2011; Farimani et al., 2012) antimalarial (Achenbach
et al., 1992) and antileishmanial (Tan et al., 2002) activities.
In our previous study, the dichloromethane/methanol (1:1) extract
of the whole plant of Salvia repens showed promising antiprotozoal ac-
tivity with a IC50 value of 5.4 μg/ml against axenically grown L. donovani
amastigotes (MHOM/ET/67/L82) (Mokoka et al., 2011). In this paperwe
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antileishmanial activity.
2. Materials and methods
2.1. Plant collection
S. repens whole plant material was collected from the Eastern Cape
Province near Aliwal-North on January 2002. The identiﬁcation of
plantmaterial was done at the South African National Biodiversity Insti-
tute (SANBI, Pretoria) where the voucher specimen (BP00998) was de-
posited. Thewet plant material was placed in an oven at 40 °C for three
days to dry, then milled to a ﬁne powder and kept at room temperature
in the dark before extraction.
2.2. Extract preparation
Finely ground plant material of S. repens (100 g) was extracted with
(2 × 1 L) of a mixture of dichloromethane and methanol (1:1, v/v)
overnight while occasionally agitating. The mixture was ﬁltered and
concentrated using a rotavapour at 40 °C and left under a stream of
cold air to dry.
2.3. HPLC activity proﬁling
The method described by Adams et al. (2009) was used for the pro-
ﬁling of S. repens extract. Brieﬂy, a 10 mg/ml sample in dimethyl sulfox-
ide (DMSO) was prepared, ﬁltered through 0.45 μm sterile ﬁlters for
HPLC fractionation. Gilson 215 liquid handler with Gilson 819 injection
module and 50 μl loop was used as the autosampler, connected to an
HPLC system consisting of a 1100 series low-pressure mixing pump
with degasser module, column oven, and a 1100 series PDA detector
(Agilent, Waldbronn, Germany). The mobile system used was made
up of water with 0.1% formic acid (A) and acetonitrile with 0.1%
formic acid (B). Separation conditions: Sunﬁre RP-18 column (3.5 μm,
3 mm × 150 mm i.d.; Waters GmbH, Eschborn, Germany), water
(A) 90–0% in acetonitrile (B) over 30 min, 100% acetonitrile (B) for
5 min. The ﬂow rate was 0.5 ml/min, and the injection volume was
35 μl (350 μg extract in DMSO). Thirty-ﬁve one-minute fractions were
collected in 96 deep well plates during the run (Screenmates 96 well,
Matrix Technology, Hudson, USA) and dried in a GeneVac EZ-2 Plus
evaporator (Genevac Ltd., Ipswich, UK). The samples were redissolved
in 5 μl of DMSO and diluted with 95 μl phosphate buffer solution
(PBS) buffer (137 mM NaCl, 10 mM phosphate, 2.7 mM KCl, pH 7.4)
for microfraction antileishmanial screening.
2.4. In vitro antileishmanial activity evaluation of the microfractions and
isolated compound
The anti-leishmanial activity of the microfractions and isolated
compound was evaluated by the method described by Adams et al.
(2009) at two different concentrations (5 μg/ml) and (0.8 μg/ml)
against L. donovani amastigotes (MHOM/ET/67/L82) in a 96-well micro-
titer plate. The plate was read in a spectramax Gemini XS microplate
ﬂuorometer (Molecular Devices Cooperation, Synnyvale, CA, USA)
using an excitation wavelength of 536 nm and emission wavelength
of 588 nm. Fluorescence development was measured and expressed
as a percentage of the control. The IC50 value was determined from
the sigmoidal inhibition curve and miltefosine was used as a positive
control.
2.5. Cytotoxicity evaluations of 12-methoxycarnosic acid against L6-cells
Assays were performed in 96-well microtiter plates, as previously
discussed by Adams et al. (2009). The plates were incubated for 72 h
and thereafter inspected under an inverted microscope to assuregrowth of the controls and sterile conditions. A volume of 10 μl of
resazurin was then added to each well and the plates incubated for a
further 2 h. The plates were then evaluated as described above. The
IC50 value was calculated from the sigmoidal inhibition curve using
SoftmaxPro software and podophylotoxin was used as a positive control.
2.6. Isolation of the active compound
The semi-preparative HPLC puriﬁcation of the DCM/MeOH (1:1)
crude extract of S. repens whole plant was performed with an HPLC
1200 series consisting of a low-pressure mixing pump with degasser
module, a column oven and a PDA detector (Agilent, Waldbronn,
Germany). A 100 mg/ml sample in DMSO was prepared and ﬁltered
through a 0.45 μm Millipore (Bedford, MA, USA) membrane ﬁlter
and several repetitions of 400 μl injections of the sample were made.
The separation was performed on a Waters Sunﬁre RP-18 column
(10 × 150 mm i.d.; 10 μm;Waters GmbH, Ireland). The mobile system
used was similar to that used for the HPLC activity proﬁling of the ex-
tract andmade up ofwater (A) and acetonitrile (B). The elution gradient
was linear from A:B (90:10) to (0:100) in 30 min at a ﬂow rate of
6.0 ml/min followed bywashing and returning to the initial elution con-
ditions (90:10) over 5 min. The separation of the active componentwas
detected at 280 nm. The targeted fraction containing the compound of
interest was collected and dried in a Genevac evaporator overnight to
afford compound 1. The structure of this compound was determined
by 1H and 13C nuclear magnetic resonance (NMR) spectroscopy and
mass spectrometry (MS) analysis as well as by comparison with the
published data and was identiﬁed as 12-methoxycarnosic acid (1)
(Richheimer et al., 1996). Using 800 mg of crude extract 10 mg of
pure compound 1 was isolated. The purity was N97% determined by
HPLC.
3. Results and discussion
TheHPLC chromatogramat 280 nmdepicted in Fig. 1made it possible
to identify the active peak responsible for the observed antileishmanial
activity. The antileishmanial activity was in fraction 27 (Fig. 1). Using
semipreparativeHPLC, 12-methoxycarnosic acid (1), a knowncompound,
was isolated and identiﬁed from its 1H and 13C NMR spectra and by com-
parison of the NMR and MS data with that published in the literature
(Richheimer et al., 1996). The compound has been isolated previously
from Salviamicrophylla (Aydoğmuş et al., 2006) and Rosmarinus ofﬁcinalis
(Richheimer et al., 1996; Oluwatuyi et al., 2004).
The antileishmanial activity of 12-methoxycarnosic acid (1) was
evaluated against axenic L. donovani amastigotes and showed an IC50
value of 0.75 μM. Miltefosine (the positive control) had an IC50 of
0.19 μM. The selectivity index (SI), calculated as the ratio between
IC50 value for cytotoxicity and IC50 value for L. donovani amastigotes
for compound (1) was 23.2.
Previous reports have shown that 1 has very interesting biological
activities. Murata et al. (2013) reported that 1 resulted in a 66.7% bind-
ing inhibition of 5α-dihydrotestosterone (DHT) to the androgen recep-
tor (AR) at 5 μM and the inhibition of 5α-reductase (IC50, 61.7 μM),
thereby playing a signiﬁcant role in promoting hair growth. To the
best of our knowledge this is the ﬁrst report on the antileishmanial
activity of 12-methoxycarnosic acid (1).
4. Conclusion
The use of HPLC-based activity proﬁling made it possible to identify
the active compound responsible for antileishmanial activity. Com-
pound (1), 12-methoxycarnosic acid isolated from S. repens showed
in vitro antileishmanial activity against axenic L. donovani amastigotes.
In addition, compound1 has good selectivity.Modiﬁcations to the struc-
ture of this compound could result in the development of new ana-
logues with much more improved activity against this parasite.
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Fig. 1.Antileishmanial activity trace of a DCM/MeOH (1:1) extract of thewhole plant of Salvia repens fractions and UV trace (280 nm) of the oneminute fractions tested against axenically
grown L. donovani amastigotes at lower concentration (0.8 μg/ml) and the chemical structure of 12-methoxycarnosic acid (1).
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